FEATURED EDITORIAL
Providing superior IP protection for genomics-related inventions already requires — and will require in the future — a more nuanced strategy combining patents, trade secrets, and copyrights.
- Designing The Next Wave Of T Cell Engagers
- AI Vs. Humans In Novel Drug Target Identification
- A Checklist For Mechanism-Based Potency Testing In Cell Therapy
- FDA RIFs Might Delay Your Review — Here Are Tips For Mitigating
- Promising Clinical Trial Updates Shared At The American Academy Of Neurology Conference
- How To Approach Tech Transfers And Sponsored Life Sciences Research In An AI Age
- Applying AI To Identify Synergistic Drug Combinations For Cancer Treatment
FEATURED APPLICATION CONTENT
-
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.
-
Delve into the intricate workflow employed for the discovery and characterization of monoclonal antibodies (mAbs) targeting the Delta spike protein.
-
Overcoming the limitations of current proximity inducers requires optimizing cooperativity. Learn how enhancing target affinity can lead to smaller, more effective therapeutics with better safety profiles.
-
Maximize your research potential by overcoming workflow bottlenecks. This piece explores flexible strategies for increasing throughput and integrating automation seamlessly into your laboratory operations.
-
Continuous processes enhance product quality, yield, and cost savings. Explore transitioning a fed-batch process to perfusion using a small batch bioreactor system to optimize cell culture conditions and comparing performances.
-
Discover how a company overcame cell generation challenges by using a system that achieves a seed ratio of 1:120 and saves four days in seed preparation time.
-
Efforts to enhance biopharmaceutical manufacturing focus on boosting production capacity sustainably and economically. Explore how optimizing processes with single-use solutions and monitoring leachables ensures product quality.
-
Discover the critical role of formulation buffer composition in stabilizing monoclonal antibodies during tangential flow filtration, a process involving ultrafiltration and diafiltration under high pressure and shear forces.
-
Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.
-
Explore how tangential flow filtration (TFF) systems streamline lentivirus purification to enhance efficiency and scalability in CAR-T cell production, which is a crucial advancement in cancer immunotherapy.
-
Stem cell research has revolutionized tissue repair and regenerative medicine. Discover how mesenchymal stem cells play a key role and offer insights into connective tissue repair, immune response, and inflammatory diseases.
FEATURED NEWS HEADLINES
- FDA Accepts Filing Application For Oral Semaglutide 25 mg, Which If Approved, Would Be The First Oral GLP-1 Treatment For Obesity
- Cadence Unveils Millennium M2000 Supercomputer With NVIDIA Blackwell Systems To Transform AI-Driven Silicon, Systems And Drug Design
- Citizen Health Partner To Support Drug Development And Long-Term Patient Outcomes In PKP2 Cardiomyopathy
- Adcentrx Therapeutics Granted Fast Track Designation For ADRX-0706 Nectin-4 ADC For The Treatment Of Advanced Cervical Cancer
- Lundbeck Joins Forces With Danish Centre For AI Innovation To Improve Brain Health By Advancing Drug Discovery With Gefion AI Supercomputer
- Accelerating Drug Discovery With A Single Carbon Atom
- Formosa Pharmaceuticals And Almac Discovery Announce Licensing Agreement For ALM-401, A First-In-Class Bispecific ADC Targeting EGFR/ROR1 For The Treatment Of Solid Tumors
- AGC Biologics Partners With Novelty Nobility For Cell Line Development And Phase I Preparations Of Antibody Drug Candidate
- Lantern Advances Drug Candidate LP-184 With IND Clearance For Phase 1b/2 Clinical Trial In Triple Negative Breast Cancer (TNBC)
- Iambic Announces Enchant v2, Its Next Generation AI Model For Predicting The Clinical Viability Of Drug Discovery Programs
ARCHIVED NEWSLETTER
- 05.06.25 -- Promising Clinical Trial Updates Shared At The American Academy Of Neurology Conference
- 04.29.25 -- FDA Issues Draft Guidance On The Use Of AI To Support Regulatory Decision-Making For Drug And Biological Products
- 04.22.25 -- How To Approach Tech Transfers And Sponsored Life Sciences Research In AI
- 04.18.25 -- Struggling With CDMO Fit, Capacity, Or Delays? Let's Solve These Challenges Together!
- 04.17.25 -- Struggling With CDMO Fit, Capacity, Or Delays? Let's Solve These Challenges Together!